Thexa Pharma Private Limited

Thexa Pharma Private Limited - pharma in Madgul, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2007PTC056165 Incorporated 01 November 2007 ROC Hyderabad HQ Madgul, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2018
₹9.03 Cr
▼ 84% YoY
Net loss · FY 2018
₹40.65 Cr
Net margin -450.2%
EBITDA · FY 2018
-₹31.75 Cr
EBITDA margin -351.7%
Authorised capital
₹14 Cr
Registered with MCA
Paid-up capital
₹12.55 Cr
Issued & subscribed
Satisfied charges
₹78.98 Cr
No open charges
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings

About Thexa Pharma Private Limited

Data last updated:

Thexa Pharma Private Limited is a private limited company based in Madgul, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 November 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC056165. The company has 3 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹14 Cr and a paid-up capital of ₹12.55 Cr. It was formerly known as Nitya Fine Chem Private Limited. It is led by directors Kiran Kumar Mamidala and Vijaya Lakshmi Ramisetti.

Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Sy. No 40/13 Kulkulpally (V) Madgul (M), Telangana, India – 509327.

As per the financials filed for FY 2018, the company reported a revenue of ₹9.03 Cr, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹40.65 Cr (net margin -450.2%) and EBITDA of -₹31.75 Cr (EBITDA margin -351.7%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.

As per MCA filings, the company has satisfied charges of ₹78.98 Cr on record. Court records list 19 cases involving the company, including 6 filed by the company and 13 filed against it; 2 cases are pending. The company has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹13.85 Cr; the latest was in August 2015. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Esschem Private Limited with revenue of ₹9.23 Cr.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website thexapharma.com.

Company Details of Thexa Pharma Private Limited
CIN U24232TG2007PTC056165
Registration Number 056165
Incorporation Date 01 November 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2018
Date of Balance Sheet 31 March 2018
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Sy. No 40/13 Kulkulpally (V) Madgul (M), Telangana, India – 509327
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Thexa Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Thexa Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Thexa Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Thexa Pharma Private Limited

The main business activity of Thexa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Thexa Pharma Private Limited FY 2018 filings available

Thexa Pharma Private Limited reported revenue of ₹9.03 Cr (down 84% YoY) for FY 2018.

Revenue · FY 2018
₹9.03 Cr ▼ 84%
Net loss · FY 2018
₹40.65 Cr margin -450.2%
EBITDA · FY 2018
-₹31.75 Cr margin -351.7%

Compounded Annual Growth Rate (CAGR) of Thexa Pharma Private Limited

Revenue CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 38%
EBITDA CAGR growth
1 year
▼ 965%
3 years · compounded
▼ 132%

Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 84% fall in the latest year. EBITDA fell 965% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Thexa Pharma Private Limited

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue₹9.03 Cr••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA-₹31.75 Cr••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)-₹40.65 Cr••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Thexa Pharma Private Limited

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-351.7%••••••••••••
Net Profit Margin-450.2%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Thexa Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Thexa Pharma Private Limited

Thexa Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Esschem Private Limited₹9.23 Cr (FY 2025)••••••••29.0%••••Mumbai, Maharashtra, India
Ratna Lifesciences Private Limited₹9.22 Cr (FY 2025)••••••••329.0%••••Hadapsar, Pune, Maharashtra, India
Omkrown Pharam-Chem Private Limited₹9.22 Cr (FY 2025)••••••••6.0%••••Nagar, Shahapur, Belgaum, Karnataka, India
Shreegen Pharma Limited₹9.2 Cr (FY 2023)••••••••-32.0%••••Hyderabad, Telangana, India
Proventus Life Sciences Private Limited₹9.17 Cr (FY 2024)••••••••-47.0%••••Chennai, Tamil Nadu, India
Thexa Pharma Private Limited this company₹9.03 Cr (FY 2018)••••••••-84.0%••••Madgul, Telangana, India
Bhisaj Pharmaceuticals Private Limited₹9 Cr (FY 2025)••••••••167.0%••••Pune, Maharashtra, India
Xenocor Pharmalab Private Limited₹8.98 Cr (FY 2024)••••••••75.0%••••Bangalore, Karnataka, India
Synthetic Molecules Private Limited₹8.88 Cr (FY 2024)••••••••49.0%••••Indore, Madhya Pradesh, India
Aptra Synthesis Private Limited₹8.84 Cr (FY 2024)••••••••-24.0%••••Hyderabad, Telangana, India
Chiral Drugs Pvt Ltd₹8.77 Cr (FY 2024)••••••••-35.0%••••Surat, Gujarat, India

Peers are the five companies nearest above and the five nearest below Thexa Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Thexa Pharma Private Limited

Thexa Pharma Private Limited is audited by V S ROOP & ASSOCIATES for the financial year 2018.

NameStatusAppointment DateCessation Date
V S ROOP & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Thexa Pharma Private Limited

Thexa Pharma has 2 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kiran Kumar MamidalaDirector11 Dec 20196 Years 10 MonthsCurrent
Vijaya Lakshmi RamisettiDirector11 Dec 20196 Years 10 MonthsCurrent

Ownership and Shareholding of Thexa Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Thexa Pharma Private Limited

Open charges
None
Satisfied charges
₹78.98 Cr
Breakdown by lending institutions
Others₹47.45 Cr
Canara Bank₹15.53 Cr
Andhra Pradesh State Financial Corporation₹9.00 Cr
Corporation Bank₹6.00 Cr
Small Industries Development Bank of India₹1.00 Cr
Latest charge details
DateLenderAmountStatus
25 May 2015Others₹39 CrSatisfied
25 May 2015Others₹8.45 CrSatisfied
11 Dec 2013Canara Bank₹15.53 CrSatisfied
30 Jun 2011Small Industries Development Bank of India₹1 CrSatisfied
03 Jun 2011Corporation Bank₹6 CrSatisfied

Total charge records: 7 View all charges

Deals & Funding of Thexa Pharma Private Limited

Thexa Pharma Private Limited has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹13.85 Cr; the latest was in August 2015.

Total deals
13
Funding rounds
7
Secondary share transfers
6
Disclosed funding
₹13.85 Cr

Deals on record (5 of 13)

WhenDealAmountParties
Aug 2015Funding round₹3.88 CrInvestors: Landmark Artha Holdings Private Limited
Feb 2015Funding round₹1.98 CrInvestors: Landmark Artha Holdings Private Limited , 2 individuals
Feb 2014Secondary share transferUndisclosedBuyer: an individual
Seller: 3 individuals
Nov 2013Funding round₹1 CrInvestors: an individual
Aug 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Premium access

Full deal history

All 13 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Thexa Pharma Private Limited

Employment history and EPFO contributions of people linked to Thexa Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Thexa Pharma Private Limited

Thexa Pharma has one previous CIN (Corporate Identification Number): U24232AP2007PTC056165. The current CIN is U24232TG2007PTC056165, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2007PTC056165Current
U24232AP2007PTC056165Previous

Recent Activity on Thexa Pharma Private Limited

Thexa Pharma Private Limited has 22 board changes on record since 2008: 2 appointments and 20 cessations. The latest: Palla Sivaiah ceased to be Company Secretary on 01 Apr 2022.

Ceased
Palla Sivaiah ceased to be Company Secretary.
Charges
A charge registered on 25 May 2015 via Charge ID 10574717 with Others was fully satisfied on 20 Dec 2021.
Charges
A charge registered on 25 May 2015 via Charge ID 10574722 with Others was fully satisfied on 20 Dec 2021.
Ceased
Pradeep Machineni ceased to be Whole-Time Director.
Ceased
Srujana Gopala Krishna Madduri ceased to be Whole-Time Director.
Ceased
Tilottam Reddy Kolanu ceased to be Whole-Time Director.
Appointed
Kiran Kumar Mamidala was appointed as Director.
Ceased
Sharat Nalamothu ceased to be Managing Director.
Ceased
Subba Rao Nallamothu ceased to be Director.
Appointed
Vijaya Lakshmi Ramisetti was appointed as Director.
Ceased
Vishali Sravanthi Madduri ceased to be Director.
AGM
Thexa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.

32 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Thexa Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Thexa Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Thexa Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Thexa Pharma Private Limited

Thexa Pharma has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
3
Cancelled / inactive
3
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Thexa Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thexa Pharma Private Limited

Thexa Pharma is an active private limited company based in Madgul, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 November 2007 (19+ years old) and is registered under CIN U24232TG2007PTC056165.

Thexa Pharma reported revenue of ₹9.03 Cr for FY 2018 (down 84% YoY).

Thexa Pharma has 2 current directors:

Thexa Pharma reported a net loss of ₹40.65 Cr (net margin -450.2%) and EBITDA of -₹31.75 Cr (EBITDA margin -351.7%) for FY 2018, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Thexa Pharma is -38% over three years. In the latest year (FY 2018) revenue fell 84%. CAGR is the steady yearly rate that links the first and the last year.

No. Thexa Pharma has 3 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Thexa Pharma is U24232TG2007PTC056165. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Thexa Pharma has 19 court cases on record: 6 filed by the company and 13 filed against it. 2 are pending. Most are in the district courts.

Thexa Pharma was incorporated on 01 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.

Thexa Pharma has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹13.85 Cr; the latest was in August 2015.

The peers of Thexa Pharma by revenue are Esschem Private Limited, Ratna Lifesciences Private Limited, Omkrown Pharam-Chem Private Limited, Shreegen Pharma Limited, Proventus Life Sciences Private Limited and 5 more, all in the Pharma industry (API Manufacturers).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available